Healthdirect Australia is not responsible for the content and advertising on the external website you are now entering.
Lagevrio TM
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.
Active ingredients: molnupiravir
Pack: Lagevrio 200 mg capsule, 40, bottle
Brand name
(ARTG)
: LAGEVRIO molnupiravir 200 mg capsules bottleDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
LAGEVRIO (molnupiravir) has provisional approval for the treatment of adults with COVID- 19 who do not require initiation of oxygen due to COVID-19 and who are at increased risk for hospitalisation or death [see Section 5.1 PHARMACODYNAMIC PROPERTIES Clinical Trials].,The decision to approve this indication has been made on the basis of the analysis of efficacy and safety data from a Phase 3 trial. Continued approval of this indication depends on additional data.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Capsule, hard
- Oral
- Swedish Orange opaque capsule with the corporate logo and 82 printed with white ink
Storage conditions
(ARTG)
- Store below 30 degrees Celsius
- Shelf lifetime is 36 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is
- 40 capsules per bottle pack
Is this medicine subsidised ?
(PBS)
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on November, 1 2024. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient molnupiravir
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
This medicine is under additional monitoring as it is new or being used in a different way. You can help identify new safety information by reporting any side effects you may get.
- You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems.
- For more information on the Black Triangle Scheme and how to report side effects, see www.tga.gov.au/black-triangle-scheme
Need more information?
These trusted information partners have more on this topic.
Top results
COVID-19 antiviral medicine - Better Health Channel
Antivirals are available for eligible people to treat COVID-19.
Read more on Better Health Channel website
Oral treatments for COVID-19 | Australian Government Department of Health and Aged Care
Learn about the different oral treatments available for COVID-19 and how to access them.
Read more on Australian Government Department of Health and Aged Care website
COVID-19 antiviral medicines – your questions answered | NSW Government
Answers to frequently asked questions about COVID-19 antiviral medicines.
Read more on NSW Health website
What you need to know about COVID-19 - Immunisation Coalition
What you need to know about COVID-19 so you can protect yourself, your friends, family and the rest of the community.
Read more on Immunisation Coalition website
Top results
RACGP - What GPs need to know about the new COVID antivirals
Reproduced with permission from The Royal Australian College of General Practitioners
Read more on RACGP - The Royal Australian College of General Practitioners website
COVID-19 Guide - Immunisation Coalition
About COVID-19 COVID-19 Cause And Transmission COVID-19 Symptoms COVID-19 Complications COVID-19 Prevention COVID-19 Vaccine Efficacy COVID-19 Vaccine Safety How Is COVID-19 Treated? About COVID-19 Coronavirus disease (COVID-19) is an infectious disease caused by the SARS-CoV-2 virus
Read more on Immunisation Coalition website
